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Hiroshima, JapanBackground and Aims: The Japan NBI Expert Team (JNET) was established in 2011 and has proposed a uni-
versal narrow-band imaging (NBI) magnifying endoscopic classiﬁcation of colorectal tumors. The aim of this study
was to evaluate the clinical usefulness of the JNET classiﬁcation for colorectal lesions.
Methods: We analyzed 2933 colorectal lesions, which were diagnosed by NBI magnifying observation before
endoscopic treatment or surgery. The colorectal lesions consisted of 136 hyperplastic polyps/sessile serrated
polyps (HPs/SSPs), 1926 low-grade dysplasia (LGD), 571 high-grade dysplasia (HGD), 87 superﬁcial submucosal
invasive (SM-s) carcinomas, and 213 deep submucosal invasive (SM-d) carcinomas. We evaluated the relationship
between the JNET classiﬁcation and the histologic ﬁndings of these lesions.
Results: The sensitivity, speciﬁcity, positive and negative predictive values, and accuracy of Type 1 lesions for the
diagnosis of HP/SSP were, respectively, 87.5%, 99.9%, 97.5%, 99.4%, and 99.3%; of Type 2A lesions for the diag-
nosis of LGD were 74.3%, 92.7%, 98.3%, 38.7%, and 77.1%; of Type 2B lesions for the diagnosis of HGD/SM-s
carcinoma were 61.9%, 82.8%, 50.9%, 88.2%, and 78.1%; for Type 3 lesions for the diagnosis of SM-d carcinoma
were 55.4%, 99.8%, 95.2%, 96.6%, and 96.6%, respectively.
Conclusions: Types 1, 2A, and 3 of the JNET classiﬁcation were very reliable indicators for HP/SSP, LGD, and
SM-d carcinoma, respectively. However, the speciﬁcity and positive predictive value of Type 2B were relatively
lower than those of others. Therefore, an additional examination such as pit pattern diagnosis using chromo-
agents is necessary for accurate diagnosis of Type 2B lesions. (Gastrointest Endosc 2017;85:816-21.)Since the development of narrow-band imaging (NBI) in
1999, it has been a reliable tool that has contributed to
improved diagnostic precision, such as detection of colo-
rectal polyps,1-4 ulcerative colitis screening,5-7 differentia-
tion of neoplastic lesions from non-neoplastic lesions,
and characterization of colorectal neoplasia.8-14 Today,
several colorectal NBI magnifying classiﬁcations, such asns: ESD, endoscopic submucosal dissection; HGD, high-grade
P, hyperplastic polyp; JNET, the Japan NBI Expert Team;
ade dysplasia; NICE classification, the NBI International
ndoscopic classification; NBI, narrow-band imaging; NPV,
dictive value; PPV, positive predictive value; SM-d, deep sub-
vasive; SM-s, superficial submucosal invasive; SSP, sessile
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ROINTESTINAL ENDOSCOPY Volume 85, No. 4 : 2017Hiroshima classiﬁcation, Sano classiﬁcation, Showa classiﬁ-
cation, and Jikei classiﬁcation, are widely used and play a
signiﬁcant role clinically as well as pit pattern diagnosis.15,16
On the other hand, in Western countries, magnifying
endoscopy is not commonly used in daily practice.
The Colon Tumor NBI Interest Group proposed a new
NBI classiﬁcation called the NBI International ColorectalCopyright ª 2017 by the American Society for Gastrointestinal Endoscopy
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Sumimoto et al JNET NBI magnifying classiﬁcationEndoscopic (NICE) classiﬁcation in 2009,17 and validation
studies were conducted in 2012.18,19 It is the ﬁrst NBI clas-
siﬁcation that can be used both with and without magni-
fying endoscopy and has therefore spread all over the
world.17,20 It is composed of 3 types that are divided ac-
cording to color, vessels, and surface pattern. Type 1 is
an indicator for hyperplastic polyp (HP), Type 3 is an indi-
cator for deep submucosal invasive (SM-d) carcinoma, and
Type 2 is an indicator for the other lesions of various his-
tologic types, including low-grade dysplasia (LGD) to su-
perﬁcial submucosal invasive (SM-s) carcinoma (Table 1).19
The NICE classiﬁcation is signiﬁcantly useful because
of its high diagnostic accuracy in detecting both non-
neoplasia that does not need to be removed and SM-d
carcinoma that needs to be resected by surgery.21,22 How-
ever, it is difﬁcult to differentiate high-grade dysplasia
(HGD) or SM-s carcinoma from LGD.17,23 This fact creates
a clinical problem. We cannot determine the mode of
endoscopic treatment, such as piecemeal endoscopic
mucosal resection (EMR) or en bloc EMR/endoscopic sub-
mucosal dissection (ESD), for NICE Type 2 lesions because
whether piecemeal EMR can be selected as a therapeutic
method is based on the histologic characteristics of the
lesions. If piecemeal EMR is not allowed for malignant
lesions, to obtain a precise histologic diagnosis of a
resected specimen we need to select ESD or surgery.15,23
To solve this issue, the Japanese NBI Expert Team
(JNET) composed of Japanese magnifying colonoscopists
was organized in 2011. Going through repeated detailed
discussion and a web-based prospective trial, the JNET
achieved consensus regarding NBI classiﬁcation, and a
new NBI colorectal magnifying classiﬁcation (the JNET clas-
siﬁcation) was proposed in 2014.24 In this study we
evaluated the clinical usefulness and problems of the
JNET classiﬁcation.METHODS
In this study, NBI magnifying observation was per-
formed at the Department of Endoscopy at Hiroshima Uni-
versity Hospital between January 2011 and March 2015. At
this time 2933 consecutive cases of colorectal lesions,
which had been endoscopically or surgically resected,
were retrospectively analyzed. On the basis of histologic
characteristics, 2933 lesions were identiﬁed as the
following: HP/sessile serrated polyp (SSP) (136 lesions),
LGD such as tubular adenoma/tubulovillous adenoma
(1926 lesions), HGD (571 lesions), SM-s carcinoma less
than 1000 mm (87 lesions), and SM-d carcinoma deeper
than 1000 mm (213 lesions).
For these lesions, 3 colonoscopists with enough experi-
ence applied the JNET classiﬁcation; the colorectal NBI
magnifying classiﬁcation consists of 4 types that are classi-
ﬁed based on vessel pattern and surface pattern. The char-
acteristics of Type 1 are invisible vessel pattern and havingwww.giejournal.orgdark and white spots as surface pattern. The characteristics
of Type 2A are regular vessel pattern, such as regular
caliber or distribution, and regular surface pattern. The
characteristics of Type 2B are irregular vessel pattern,
such as variable caliber, irregular distribution, and irregular
or obscure surface pattern. The characteristics of Type 3
are loose vessel areas or interruption of thick vessels
and amorphous surface pattern (Fig. 1). These 3
colonoscopists were not involved in the endoscopic
diagnosis of the lesions, and evaluation was performed
objectively. In this process, the colonoscopists were
blinded to all information concerning the endoscopic
images and histopathologic ﬁndings.
The instrument used in this study was a magnifying
videoendoscope system (CF-H260AZI; Olympus, Tokyo,
Japan). The resected lesions were pathologically diagnosed
in accordance with the criteria of the World Health Organi-
zation.25 One pathologist diagnosed all cases without any
clinical information. Using these cases, we examined the
relationship between each type of the JNET classiﬁcation
and histopathologic ﬁndings. The study protocol was
approved by the Ethics Committee of Hiroshima University.
Statistical analysis
We calculated sensitivity, speciﬁcity, positive and nega-
tive predictive value (PPV and NPV), and accuracy for
each category of the classiﬁcation. The criterion standard
for validation of predictions was the histology of colorectal
lesions.
To calculate the interobserver agreement, we selected
recent consecutive 1000 lesions. All 3 colonoscopists,
who were blinded to all clinical information of lesions con-
cerning endoscopic images and histopathologic ﬁndings,
diagnosed NBI magnifying images simultaneously and re-
corded each JNET classiﬁcation diagnosis. The interob-
server agreement results based on the value of kappa
statistics were deﬁned as follows: poor, .2; fair, .21 to .4;
moderate, .41 to .6; substantial, .61 to .8; and excellent,
.81 to 1.RESULTS
The relationship between NBI magniﬁcation ﬁndings
and the histologic features of the colorectal lesions is
shown in Table 2. Histologically, 98% (119/122) and 2%
(3/122) of Type 1 lesions were identiﬁed as HP/SSP and
LGD, respectively. In addition, 1% (17/1888), 86%
(1626/1888), and 13% (245/1888) of Type 2A lesions were
identiﬁed as HP/SSP, LGD, and HGD–SM-s carcinoma,
respectively. Thirty-seven percent (297/799), 51% (407/
799), and 12% (95/799) of Type 2B lesions were identiﬁed
as LGD, HGD–SM-s carcinoma, and SM-d carcinoma,
respectively. Five percent (5/124) and 95% (118/124) of
Type 3 lesions were identiﬁed as HGD–SM-s carcinoma
and SM-d carcinoma, respectively. The difference in theVolume 85, No. 4 : 2017 GASTROINTESTINAL ENDOSCOPY 817
Figure 1. Japanese NBI Expert Team classiﬁcation system.
TABLE 1. NBI International Colorectal Endoscopic (NICE) classification*
Type 1 Type 2 Type 3
Color Same or lighter than
background
Browner relative to background
(verify color arises from vessels)
Brown to dark brown relative
to background; sometimes
patchy whiter areas
Vessels None, or isolated lacy vessels
may be present coursing
across the lesion
Brown vessels surrounding
white structuresy
Has area(s) with disrupted
or missing vessels
Surface pattern Dark or white spots of
uniform size, or
homogenous absence
of pattern
Oval, tubular, or branched
white structuresy surrounded
by brown vessels
Amorphous or absence
of pattern
Most likely
pathology
Hyperplastic & sessile serrated polyp (SSP)z Adenomax Deep submucosal invasive cancer
*Can be applied using colonoscopes both with or without optical (zoom) magnification.
yThese structures (regular or irregular) may represent the pits and the epithelium of the crypt opening.
zIn the World Health Organization classification,25 sessile serrated polyp and sessile serrated adenoma are synonymous.
xType 2 consists of Vienna classification types 3, 4, and superficial 5 (all adenomas with either low and high grade dysplasia, or with superficial submucosal carcinoma). The
presence of high grade dysplasia or superficial submucosal carcinoma may be suggested by an irregular vessel or surface pattern and is often associated with atypical
morphology (eg, depressed area).
JNET NBI magnifying classiﬁcation Sumimoto et alpercentage of HP/SSP versus LGD among Type 1 lesions
was signiﬁcant. The difference in the percentage of LGD
versus HGD–SM-s carcinoma among Type 2A lesions was
also signiﬁcant, as was the difference in the percentage
of SM-d carcinoma versus HGD–SM-s carcinoma among818 GASTROINTESTINAL ENDOSCOPY Volume 85, No. 4 : 2017Type 3 lesions. However, the percentages of HGD–SM-s
carcinoma and LGD among Type 2B were similar; both
were nearly 40%.
The diagnostic characteristics of each category are
shown in Table 3. The sensitivity, speciﬁcity, PPV, NPV,www.giejournal.org
TABLE 2. Relationship between the JNET classification and histologic findings in colorectal lesions
JNET classification N (%)
Histologic findings
HP/SSP LGD HGD
Carcinoma
SM-s SM-d
Type 1 122 (100) 119 (98) 3 (2)
Type 2A 1888 (100) 17 (1) 1626 (86) 230 (12) 15 (1)
Type 2B 799 (100) 297 (37) 340 (43) 67 (8) 95 (12)
Type 3 124 (100) 1 (1) 5 (4) 118 (95)
Total 2933 136 1926 571 87 213
Values are total number of cases with percents in parentheses.
TABLE 3. Performance characteristics of each type of the JNET classification*
JNET classification Sensitivity Specificity PPV NPV Accuracy
Type 1 87.5 (81.9-93.1) 99.9 (99.8-100.0) 97.5 (94.8-100.3) 99.4 (99.1-99.7) 99.3 (99.0-99.6)
Type 2A 74.3 (72.6-76.0) 92.7 (90.2-95.1) 98.3 (97.7-98.9) 38.7 (35.7-41.6) 77.1 (75.5-78.6)
Type 2B 61.9 (58.1-65.6) 82.8 (81.2-84.3) 50.9 (47.5-54.4) 88.2 (86.9-89.6) 78.1 (76.6-79.6)
Type 3 55.4 (48.7-62.1) 99.8 (99.6-100.0) 95.2 (91.4-98.9) 96.6 (95.9-97.3) 96.6 (95.9-97.2)
*Values are percents with 95% confidence interval in parentheses.
Figure 2. Strategy for endoscopic treatment of colorectal lesions. NBI, narrow-band imaging; IEE, image-enhanced endoscopy; WLI, white light imaging;
EUS, endoscopic ultrasonography.
Sumimoto et al JNET NBI magnifying classiﬁcationand accuracy of Type 1 lesions for the diagnosis of
HP/SSP were 87.5%, 99.9%, 97.5%, 99.4%, and 99.3%,
respectively. The sensitivity, speciﬁcity, PPV, NPV, and
accuracy of Type 2A lesions for the diagnosis of LGD
were 74.3%, 92.7%, 98.3%, 38.7%, and 77.1%,
respectively, and those of Type 2B lesions for the
diagnosis of HGD–SM-s carcinoma were 61.9%, 82.8%,
50.9%, 88.2%, and 78.1%, respectively. Last, the
sensitivity, speciﬁcity, PPV, NPV, and accuracy of Type 3
lesions for the diagnosis of SM-d carcinoma werewww.giejournal.org55.4%, 99.8%, 95.2%, 96.6%, and 96.6%, respectively.
The overall interobserver agreement was good
(k Z .749).DISCUSSION
Removal of all adenomatous polyps has been standard-
ized in Western countries because it can reduce colorectal
cancer incidence and mortality.26,27 It is therefore routineVolume 85, No. 4 : 2017 GASTROINTESTINAL ENDOSCOPY 819
JNET NBI magnifying classiﬁcation Sumimoto et alpractice to retrieve polyps and collect them for pathologic
evaluation. The interval of time to next surveillance colonos-
copy can be only decided according to the ﬁnal histologic
diagnosis.28 The “Resect and Discard” policy has been
advocated29-32 and states that an HP should be left in order
to reduce the adverse events of polypectomy and cost of
medical care.28,33-35 On the other hand, SM-d carcinoma is
generally an indication for surgery because of its high risk
of lymph node metastasis. The NICE classiﬁcation is simple
and very useful in identifying the lesions that do not need
treatment and those that warrant surgery.17,19,36
As reported previously, lesions showing NICE Type 2
include various lesions from LGD to SM-s carcinoma.
Generally, piecemeal EMR can be allowed for benign
adenoma. However, HGD–SM-s carcinoma should be
completely resected by en bloc EMR or ESD to obtain a
precise histologic diagnosis for judgment of curability,
including the risk stratiﬁcation of lymph node metastasis.
Therefore, the diagnosis of NICE Type 2 is insufﬁcient
for the correct selection of a therapeutic method, such
as piecemeal EMR or ESD.17
To distinguish LGD from HGD–SM-s carcinoma, magni-
fying detailed observation is needed.14,32,37-40 To solve this
problem and unify the various NBI classiﬁcations in Japan,
the JNET was established in 2011, and a new NBI classiﬁca-
tion with magniﬁcation (the JNET classiﬁcation) was pro-
posed in 2015.24 The principles and characteristics of the
JNET classiﬁcation are as follows: (1) the use of
magniﬁcation is essential and the base is the NICE
classiﬁcation; (2) in the JNET classiﬁcation, NICE Type 2
is divided into 2 subtypes (2A and 2B) using magnifying
ﬁndings; (3) because magniﬁcation does not need
estimation of color, the JNET classiﬁcation does not
include the ﬁnding of color; and (4) basic ﬁndings are
composed of both vessel pattern and surface pattern.
Our results in this study showed the sensitivity, speci-
ﬁcity, PPV, NPV, and accuracy of each type for the most
likely kind of histology found in the JNET classiﬁcation.
Types 1, 2A, and 3 have a speciﬁcity over 90% and a high
PPV over 95%. This means that Types 1, 2A, and 3 of the
JNET classiﬁcation are deﬁnite indicators of their respec-
tive most likely histology, with signiﬁcant diagnostic accu-
racy. On the other hand, the speciﬁcity of Type 2B was
82.8% and PPV of Type 2B was 50.9%, signiﬁcantly lower
than those of the others. Thus, the ability of Type 2B to
identify HGD–SM-s carcinoma is not signiﬁcant. This may
be because of the variety of Type 2B lesions; Types 1,
2A, and 3 lesions correspond to their respective most likely
histology, which occupies more than 95% of each
type (HP/SSP for Type 1, LGD for Type 2A, and SM-d
carcinoma for Type 3). The lesions with irregular vessel
and irregular surface patterns are classiﬁed as Type 2B,
and show various histologic ﬁndings, ranging from LGD
to SM-d carcinoma.
According to these results, in daily practice the JNET
classiﬁcation is useful for characterization of colorectal820 GASTROINTESTINAL ENDOSCOPY Volume 85, No. 4 : 2017lesions of Types 1, 2A, and 3. Being different from detec-
tion of tumor in screening colonoscopy in which sensitivity
is important, in the diagnosis before treatment the speci-
ﬁcity of the classiﬁcation is more reliable and important
for determining the adequate treatment method for each
lesion. On the other hand, lesions of Type 2B need an
additional pit pattern diagnosis using magniﬁcation with
chromoagents such as indigo carmine or crystal vio-
let.21,37,41,42 Of course, even for the diagnosis of Types 1,
2A, and 3, if the conﬁdence level is low, an additional pit
pattern diagnosis using chromoagents should be applied
(Fig. 2).23,43 At present, the optical zoom magnifying endo-
scope is not widely used in clinical practice in Western
countries; however, recently the use of magniﬁcation has
been increasing step by step all over the world. The Exela
III and Lucera Elite systems (Olympus), recently developed
videoendoscope systems and also used in Western coun-
tries, have a function of dual focus with electronic zoom,
providing almost the same image of optical zoom magni-
fying images. Thus, magniﬁcation has gradually become
common, and it is expected to become standard in the
near future. Also, dye spray chromoendoscopy is expected
to become common in relation to the spread of
magniﬁcation.
Finally, the NICE classiﬁcation has been used practi-
cally worldwide without requiring the technique of
magnifying endoscopy because of its simplicity, conve-
nience, high accuracy, and practical usefulness for diagno-
ses and decisions regarding treatment methods.12,17,18
The recently proposed JNET classiﬁcation is a uniﬁed,
detailed Japanese magnifying NBI classiﬁcation based on
this NICE classiﬁcation. In this study, we preliminarily
examined the characteristics and pitfalls of the JNET clas-
siﬁcation. A detailed validation study of the JNET classiﬁ-
cation, including the diagnostic ability of the relationship
with each NBI magnifying ﬁnding, is now ongoing by
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Sumimoto et al Diagnostic performance of JNET classiﬁcationThe narrow-band imaging (NBI) system has been used
widely to diagnose GI neoplasia since it was ﬁrst developed
in 1999 in Japan.1,2 Many reports have conﬁrmed that NBI
observation is useful for detecting colorectal tumors,3-5
differentiating between neoplastic and non-neoplastic
colorectal lesions,6,7 and diagnosing the invasive depth of
colorectal carcinomas.2,8-10 As such, NBI classiﬁcations
have become an important and necessary modality for
daily colonoscopic examinations. In 2009, the Colon Tu-
mor NBI Interest Group (CTNIG) proposed an NBI classi-
ﬁcation for colorectal tumors, the NBI International
Colorectal Endoscopic (NICE) classiﬁcation.11-13 NICE clas-
siﬁcation was the ﬁrst classiﬁcation for colon tumors that
could be applied with or without magnifying observation.14
Because of its simplicity and usefulness, NICE classiﬁcation
spread rapidly in Western countries, where NBI
magniﬁcation had not yet become common.9,15
In Japan, many NBI magnifying classiﬁcations for colon tu-
mors were used, such as Hiroshima classiﬁcation,16-19 Sano
classiﬁcation,20,21 Showa classiﬁcation,22 and Jikei
classiﬁcation,23 each used at different facilities. To unify the
classiﬁcations, a committee of 38 magnifying colonoscopy
specialists in Japan, the Japan NBI Expert Team (JNET), was
organized in 2011. In 2014 JNET proposed the ﬁrst uniﬁed
colorectal NBI magnifying classiﬁcation, the JNET
classiﬁcation.24 The JNET classiﬁcation is composed of 4
types, types 1, 2A, 2B, and 3, and 2 NBI magnifying ﬁndings,
surface pattern and vessel pattern. Types 1, 2A, 2B, and 3
are intended to indicate the most likely histology. Type 1
refers to hyperplastic polyps (HPs) and sessile serrated
polyps (SSPs). Type 2A refers to low-grade dysplasias
(LGDs), such as tubular adenomas or tubulovillous ade-
nomas. Type 2B refers to high-grade dysplasias (HGDs) and
superﬁcial submucosal invasive (SM-s) carcinomas. Type 3 re-
fers to deep submucosal invasive (SM-d) carcinomas. As we
have previously reported, Types 1, 2A, and 3 are highly reli-
able indicators for their respective most likely histology,
with signiﬁcant qualitative and quantitative accuracy.25 On
the other hand, the ability of Type 2B to indicate HGD and
SM-s carcinoma is weaker than the abilities of the other 3
types, because Type 2B contains lesions with a variety of his-
tology, ranging from LGD to SM-d carcinoma. Although a va-
riety of gross types of colorectal tumors exhibit different
clinical behaviors in terms of growth or invasion,26,27 differ-
ences in thediagnostic performanceof the JNETclassiﬁcation
have not been reported according to gross type. This study
aimed to evaluate the diagnostic performance of the JNET
classiﬁcation for each gross type of lesion and to determine
whether further subtyping of Type 2B could improve diag-
nostic performance.METHODS
This study included 2933 consecutive cases of colo-
rectal lesions that had been endoscopically or surgicallywww.giejournal.orgresected. A total of 1901 patients were enrolled; 1351
patients (71.1%) had 1 lesion, 314 patients (16.5%) had
2 lesions, 132 patients (6.9%) had 3 lesions, and 104
patients (5.5%) had 4 or more lesions. All lesions were
assumed to be independent observations for the pur-
pose of statistical analysis. Each case was examined by
NBI magnifying observation at the Department of Endos-
copy of Hiroshima University Hospital between January
2011 and March 2015. Based on their histologic charac-
teristics, 2933 lesions were identiﬁed as follows: 136
HP/SSP lesions, 1926 LGD lesions, 571 HGD lesions, 87
SM-s carcinoma lesions, and 213 SM-d carcinoma lesions.
The mean diameters (standard deviations) of the HP/
SSP, LGD, HGD, SM-s carcinoma, and SM-d carcinoma
lesions were 8.9 (7.6) mm, 11.4 (10.7) mm, 25.7
(17.3) mm, 25.1 (13.9) mm, and 26.0 (14.3) mm,
respectively.
The NBI criteria for each type from the JNET classiﬁca-
tion are described in Figure 1. Type 1 lesions are
characterized by an invisible vessel pattern with dark
and white spots as the surface pattern. Type 2A lesions
are characterized by a regular vessel pattern, such as a
regular caliber or distribution, and a regular surface
pattern. Type 2B lesions are characterized by an
irregular vessel pattern, such as a variable caliber or
irregular distribution, with an irregular or obscure
surface pattern. Type 3 lesions are characterized by
loose vessel areas or interruption of thick vessels and
an amorphous surface pattern.
First, we evaluated the diagnostic performance of each
JNET type in terms of its ability to predict the most likely
histology. To compare differences in diagnostic accuracy
between each gross type, we classiﬁed the lesions as
polypoid or superﬁcial according to the Paris classiﬁcation
and then evaluated the diagnostic performance for each
group.28 To evaluate the diagnostic ability as an
indicator of the most likely histology, we calculated
sensitivity, speciﬁcity, positive and negative predictive
values, and accuracy for each type of JNET classiﬁcation.
Histologic ﬁndings of the colorectal lesions were used
as the standard against which the optical predictions
were validated.
Second, we subclassiﬁed 799 consecutive Type 2B
lesions into 2B-low and 2B-high subtypes. We used
blinded NBI magnifying endoscopic images and arrived
at a diagnosis retrospectively, based on the levels of irreg-
ularity in the vessel and surface patterns. Type 2B-low
lesions exhibited uniform thickness and a uniform distri-
bution of irregular vessels, an irregularity in the network
of the pit-like pattern, and a smooth margin of the pit-
like structure without ravage. Type 2B-high lesions
exhibited heterogeneous diameters and/or distributions
of irregular vessels, an irregular and destroyed pit-like
pattern, and an irregular, ﬂufﬁng, unclear margin of the
pit-like structure (Fig. 2). We evaluated the relationships
between each of the Type 2B subtypes and histologyVolume 86, No. 4 : 2017 GASTROINTESTINAL ENDOSCOPY 701
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Examples
Japanese NBI Expert Team (JNET) classification
• Invisible
• Similar to surrounding
normal mucosa
Hyperplastic polyp/
Sessile serrated polyp
• Variable caliber
• Irregular or obscure
High-grade intramucosal
neoplasia/ Superficial
submucosal invasive cancer
• Loose vessel areas
• Interruption of thick
vessels
• Amorphous areas
Deep submucosal
invasive cancer
1. If visible, the caliber in the lesion is similar to surrounding normal mucosa.
2. Microvessels are often distributed in a punctate pattern and well-ordered reticular or spiral vessels may not be observed in depressed lesions.
3. Deep submucosal invasive cancer may be included.
4. Low-grade intramucosal neoplasia: low-grade dysplasia.
5. High-grade intramucosal neoplasia: high-grade dysplasia.
• Irregular distribution
• Regular caliber
• Regular distribution
(meshed/spiral pattern)
• Regular
(tubular/branched/papillary)
Low-grade intramucosal
neoplasia
• Regular dark or white
spots
Figure 1. The Japan NBI Expert Team classiﬁcation (narrow-band imaging [NBI] magnifying classiﬁcation for colorectal neoplasia).
Diagnostic performance of JNET classiﬁcation Sumimoto et alresults. Interobserver and intraobserver variabilities were
estimated. The relationships between the Type 2B
subtypes and histology results were also examined for
each gross type.
To evaluate the NBI magnifying images, the lesions
were diagnosed according to the JNET classiﬁcation by
3 proﬁcient endoscopists, each of whom had at least 5
years of experience using NBI. The endoscopists were
blinded to all clinical information on the lesions that
was related to the standard endoscopic images and his-
tology results. They arrived at the diagnoses based
on the NBI magnifying images alone. Interobserver
variability for the Type 2B subtyping was analyzed for
the 3 endoscopists and the kappa value calculated. Of
the 799 cases that were diagnosed as Type 2B, the anal-
ysis of interobserver and intraobserver variability used
the 216 consecutive cases that were detected by colo-
noscopy between January 2014 and November 2014.
We used the NBI magnifying still images with 1 image
per lesion. Two weeks after making the ﬁrst diagnosis,
and without undergoing any speciﬁc training for NBI
diagnosis during that time, 1 of 3 participating endo-
scopists was presented with the NBI magnifying images
from the same 216 cases in a different order. To analyze
intraobserver variability, she then subclassiﬁed them702 GASTROINTESTINAL ENDOSCOPY Volume 86, No. 4 : 2017again, while remaining blinded to the results from the
ﬁrst trial.
The colonoscope used in this study was a magnifying
videoendoscope (CF-H260AZI and CF-HQ290ZI;
Olympus Optical, Tokyo, Japan). The maximum magniﬁ-
cation level in this study was approximately 70-fold for
each scope. Histologic diagnosis was performed in
accordance with the World Health Organization criteria
by a pathologist (F. S.) who was blinded to the clinical
information.29 The depth of SM invasion was deﬁned
according to the 2014 Japanese Society for Cancer of
the Colon and Rectum guidelines for the treatment of
colorectal cancer.30 This study was conducted with full
approval from the Ethics Committee of Hiroshima
University Hospital.
Statistical analysis
The kappa values for interobserver and intraobserver
agreement were interpreted as follows: poor, .00 to .20;
fair, .21 to .40; moderate, .41 to .60; substantial, .61 to
.80; and excellent, .81 to 1.00.31 Kappa values provide a
measure of the agreement that is present, above and
beyond that which would be expected from chance
alone. A kappa value of 1.00 indicates perfect agreement,
a value of .00 indicates no more agreement than wouldwww.giejournal.org
NBI
Type 2B
2B-low 2B-high
•     The thickness and distribution of irregular
       vessels are uniform.
•     Irregularity in the pit-like pattern network
•     Smooth pit-like structure margin without
       ravaging
•     The diameter and/or distribution of
       irregular vessels are heterogeneous.
•     Irregular and destroyed pit-like pattern
•     Irregular, fluffing, and unclear pit-like
       structure margin
Vessel
pattern
Surface
pattern
Examples
Figure 2. Subtyping of Japan NBI Expert Team Type 2B. NBI, Narrow-band imaging.
Sumimoto et al Diagnostic performance of JNET classiﬁcationbe expected by chance alone, and a negative value
indicates less agreement than would be expected from
chance alone. Differences in nominal variables were
analyzed using the Fisher exact test. P < .05 was
considered statistically signiﬁcant. JMP version 10.0 (SAS
Institute, Cary, NC) was used for all statistical analysis.
Although there was multiple testing of outcome data
arising from individual lesions, no corrections to the P
values were made because the purpose of the research
was to highlight any potential differences.RESULTS
Relationships between the JNET classiﬁcation
and histologic ﬁndings for each gross type
The results of NBI magnifying endoscopic diagnoses for
all 2933 lesions using the JNET classiﬁcation are shown in
Table 1. According to the Paris classiﬁcation, 2114 of the
2933 lesions were categorized as polypoid lesions (0-Is
and 0-Ip) and the remaining 819 as superﬁcial lesions
(0-IIa, 0-IIb, and 0-IIc).
The 2114 polypoid-type lesions consisted of 57 HP/SSP
lesions, 1435 LGD lesions, 431 HGD lesions, 50 SM-s car-
cinoma lesions, and 141 SM-d carcinoma lesions
(Table 2). Histologically, 98% (46/47) and 2% (1/47) of
Type 1 lesions were identiﬁed as HP/SSP and LGD,
respectively. One percent (11/1,460), 86% (1,253/1,460),
and 14% (196/1,460) of Type 2A lesions were identiﬁed
as HP/SSP, LGD, and HGD/SM-s carcinoma, respectively.
Thirty-four percent (181/531), 54% (283/531), and 13%
(67/531) of Type 2B lesions were identiﬁed as LGD,www.giejournal.orgHGD/SM-s carcinoma, and SM-d carcinoma, respectively.
Three percent (2/76) and 97% (74/76) of Type 3 lesions
were identiﬁed as SM-s carcinoma and SM-d carcinoma,
respectively.
The 819 superﬁcial-type lesions consisted of 79 HP/SSP
lesions, 491 LGD lesions, 140 HGD lesions, 37 SM-s carci-
noma lesions, and 72 SM-d carcinoma lesions (Table 3).
Histologically, 97% (73/75) and 3% (2/75) of Type 1
lesions were identiﬁed as HP/SSP and LGD, respectively.
One percent (6/428), 87% (373/428), and 12% (49/428)
of Type 2A lesions were identiﬁed as HP/SSP, LGD, and
HGD/SM-s carcinoma, respectively. Forty-three percent
(116/268), 47% (124/268), and 10% (28/268) of Type 2B
lesions were identiﬁed as LGD, HGD/SM-s carcinoma,
and SM-d carcinoma, respectively. Eight percent (4/48)
and 92% (44/48) of Type 3 lesions were identiﬁed as
HGD/SM-s carcinoma and SM-d carcinoma, respectively.
The relationships of the JNET classiﬁcations and their
respective most likely histologic ﬁndings for both
polypoid lesions and superﬁcial lesions are shown in
Table 4. No signiﬁcant difference was observed for any
types in the JNET classiﬁcation (P > .5).Performance characteristics of the JNET
classiﬁcation for each gross type
The sensitivity, speciﬁcity, positive predictive value,
negative predictive value, and accuracy of the Type 1 clas-
siﬁcation as a means of diagnosing HP/SSP were 80.7%,
100.0%, 97.9%, 99.5%, and 99.4% for polypoid lesions
and 92.4%, 99.7%, 97.3%, 99.2%, and 99.0% for superﬁcial
lesions, respectively. The corresponding values for theVolume 86, No. 4 : 2017 GASTROINTESTINAL ENDOSCOPY 703
TABLE 1. The relationship between the JNET classification and histologic findings in colorectal lesion
JNET classification n, (%)
Histologic findings
HP/SSP LGD HGD
Carcinoma
SM-s SM-d
Type 1 122 (100) 119 (98) 3 (2)
Type 2A 1888 (100) 17 (1) 1626 (86) 230 (12) 15 (1)
Type 2B 799 (100) 297 (37) 340 (43) 67 (8) 95 (12)
Type 3 124 (100) 1 (1) 5 (4) 118 (95)
Total 2933 136 1926 571 87 213
JNET, Japan NBI Expert Team; HP, hyperplastic lesion; SSP, sessile serrated polyp; LGD, low-grade dysplasia; HGD, high-grade dysplasia; SM-s, superficial submucosal invasive
carcinoma (<1000 mm); SM-d, deep submucosal invasive carcinoma (1000 mm).
TABLE 2. Relationship between the JNET classification and histologic findings for polypoid colorectal lesion
JNET classification n, (%)
Histologic findings
HP/SSP LGD HGD
Carcinoma
SM-s SM-d
Type 1 47 (100) 46 (98) 1 (2)
Type 2A 1460 (100) 11 (1) 1253 (86) 184 (13) 12 (1)
Type 2B 531 (100) 181 (34) 247 (47) 36 (7) 67 (13)
Type 3 76 (100) 2 (3) 74 (97)
Total 2114 57 1435 431 50 141
JNET, Japan NBI Expert Team; HP, hyperplastic lesion; SSP, sessile serrated polyp; LGD, low-grade dysplasia; HGD, high-grade dysplasia; SM-s, superficial submucosal invasive
carcinoma (<1000 mm); SM-d, deep submucosal invasive carcinoma (1000 mm).
TABLE 3. Relationship between the JNET classification and histologic findings for superficial colorectal lesion
JNET classification n, (%)
Histologic findings
HP/SSP LGD HGD
Carcinoma
SM-s SM-d
Type 1 75 (100) 73 (97) 2 (3)
Type 2A 428 (100) 6 (1) 373 (87) 46 (11) 3 (1)
Type 2B 268 (100) 116 (43) 93 (35) 31 (12) 28 (10)
Type 3 48 (100) 1 (2) 3 (6) 44 (92)
Total 819 79 491 140 37 72
JNET, Japan NBI Expert Team; HP, hyperplastic lesion; SSP, sessile serrated polyp; LGD, low-grade dysplasia; HGD, high-grade dysplasia; SM-s, superficial submucosal invasive
carcinoma (<1000 mm); SM-d, deep submucosal invasive carcinoma (1000 mm).
Diagnostic performance of JNET classiﬁcation Sumimoto et alType 2A classiﬁcation as a means of diagnosing LGD
were 77.0%, 90.7%, 98.4%, 34.4%, and 77.1% for polypoid
lesions and 66.4%, 95.2%, 97.9%, 45.9%, and 73.0% for
superﬁcial lesions, respectively. Further, the correspond-
ing values for the Type 2B classiﬁcation as a means of
diagnosing HGD or SM-s carcinoma were 58.8%, 84.8%,
53.3%, 87.5%, and 78.9% for polypoid lesions and
70.1%, 77.6%, 46.3%, 90.4%, and 76.0% for superﬁcial le-
sions, respectively. Finally, the sensitivity, speciﬁcity, pos-
itive predictive value, negative predictive value, and
accuracy of the Type 3 categorization as a means of diag-
nosing SM-d carcinoma were 52.5%, 99.7%, 92.5%, 96.7%,
and 96.5% for polypoid lesions and 61.1%, 99.5%, 91.7%,704 GASTROINTESTINAL ENDOSCOPY Volume 86, No. 4 : 201796.4%, and 96.1% for superﬁcial lesions, respectively
(Table 5).
Relationships between the JNET classiﬁcation
with Type 2B subtyping and histologic ﬁndings
for all colorectal lesions
The 799 Type 2B lesions were subclassiﬁed into 656
Type 2B-low lesions and 143 Type 2B-high lesions
(Table 6). Histologically, the 656 Type 2B-low lesions
consisted of 297 LGDs (45%), 351 HGDs/SM-s carcinomas
(54%), and 8 SM-d carcinomas (1%), whereas the 143 Type
2B-high lesions consisted of 56 HGDs/SM-s carcinomas
(39%) and 87 SM-d carcinomas (61%).www.giejournal.org
TABLE 4. Relationship between the JNET classification and histologic findings in polypoid type and superficial type
JNET classification Gross type Histologic findings(%) P value*
HP/SSP Non-HP/SSP
Type 1 Polypoid 46 (98) 1 (2) 1.000
Superficial 73 (97) 2 (3)
LGD Non-LGD
Type 2A Polypoid 1253 (86) 207 (14) .485
Superficial 373 (87) 55 (13)
HGD/SM-s Non-HGD/SM-s
Type 2B Polypoid 263 (54) 248 (46) .061
Superficial 124 (47) 144 (53)
SM-d Non-SM-d
Type 3 Polypoid 74 (97) 2 (3) .312
Superficial 44 (92) 4 (8)
JNET, Japan NBI Expert Team; HP, hyperplastic lesion; SSP, sessile serrated polyp; LGD, low-grade dysplasia; HGD, high-grade dysplasia; SM-s, superficial submucosal invasive
carcinoma (<1000 mm); SM-d, deep submucosal invasive carcinoma (1000 mm).
*c2 test.
TABLE 5. Performance characteristics of JNET classification in each gross type
JNET classification Gross type Sensitivity Specificity Positive predictive value Negative predictive value Accuracy
Type 1 All 87.5 (81.9-93.1) 99.9 (99.8-100.0) 97.5 (94.8-100.3) 99.4 (99.1-99.7) 99.3 (99.0-99.6)
Polypoid 80.7 (70.5-90.9) 100.0 (99.9-100.0) 97.9 (93.7-102.0) 99.5 (99.2-99.8) 99.4 (99.1-99.8)
Superficial 92.4 (86.6-98.2) 99.7 (99.4-100.1) 97.3 (93.7-101.0) 99.2 (98.6-99.8) 99.0 (98.4-99.7)
Type 2A All 74.3 (72.6-76.0) 92.7 (90.2-95.1) 98.3 (97.7-98.9) 38.7 (35.7-41.6) 77.1 (75.5-78.6)
Polypoid 77.0 (75.1-78.9) 90.7 (87.1-94.3) 98.4 (97.8-99.1) 34.4 (30.8-38.0) 77.1 (75.5-78.6)
Superficial 66.4 (62.7-70.1) 95.2 (92.2-98.3) 97.9 (96.5-99.3) 45.9 (41.0-50.9) 73.0 (70.0-76.1)
Type 2B All 61.9 (58.1-65.6) 82.8 (81.2-84.3) 50.9 (47.5-54.4) 88.2 (86.9-89.6) 78.1 (76.6-79.6)
Polypoid 58.8 (54.4-63.2) 84.8 (83.1-86.6) 53.3 (49.1-57.5) 87.5 (85.9-89.1) 78.9 (77.2-80.6)
Superficial 70.1 (63.3-76.8) 77.6 (74.4-80.8) 46.3 (40.3-52.2) 90.4 (87.9-92.9) 76.0 (73.1-78.9)
Type 3 All 55.4 (48.7-62.1) 99.8 (99.6-100.0) 95.2 (91.4-98.9) 96.6 (95.9-97.3) 96.6 (95.9-97.2)
Polypoid 52.5 (44.2-60.7) 99.7 (99.5-99.9) 92.5 (86.7-98.3) 96.7 (95.9-97.5) 96.5 (95.8-97.3)
Superficial 61.1 (49.9-72.4) 99.5 (98.9-100.0) 91.7 (83.8-99.5) 96.4 (95.1-97.7) 96.1 (94.8-97.4)
Values are percents with 95% confidence intervals in parentheses.
JNET, Japan NBI Expert Team; NBI, narrow-band imaging.
Sumimoto et al Diagnostic performance of JNET classiﬁcationThe overall interobserver agreement for Type 2B sub-
typing among the 3 endoscopists was good, with a kappa
value of .743 (95% conﬁdence interval, .671-.823). The
intraobserver agreement was also good for the endoscopist
who was evaluated, with a kappa value of .786 (95% conﬁ-
dence interval, .691-.884).
Relationships between the JNET classiﬁcation
with Type 2B subtyping and histologic ﬁndings
for colorectal lesions of each gross type
Of the 799 Type 2B lesions, 531 were polypoid type and
268 were superﬁcial type. The 531 polypoid lesions of
Type 2B were subclassiﬁed into 437 Type 2B-low lesions
and 94 Type 2B-high lesions (Table 7). Histologically, thewww.giejournal.org437 Type 2B-low lesions consisted of 181 LGDs (41%),
248 HGDs/SM-s carcinomas (57%), and 8 SM-
d carcinomas (2%), whereas the 94 Type 2B-high lesions
consisted of 35 HGDs/SM-s carcinomas (37%) and 59 SM-
d carcinomas (63%). The 268 superﬁcial lesions of Type
2B were subclassiﬁed into 219 Type 2B-low lesions and
49 Type 2B-high lesions (Table 8). Histologically, the 219
Type 2B-low lesions consisted of 116 LGDs (53%) and
103 HGDs/SM-s carcinomas (47%), whereas the 49 Type
2B-high lesions consisted of 21 HGDs/SM-s carcinomas
(43%) and 28 SM-d carcinomas (57%). There was no signif-
icant difference in the relationship of Type 2B subtyping
and histologic ﬁndings between polypoid lesions and su-
perﬁcial lesions, although a nearly signiﬁcant differenceVolume 86, No. 4 : 2017 GASTROINTESTINAL ENDOSCOPY 705
TABLE 7. Relationship between the JNET classification with subtyping of Type 2B and histologic findings in polypoid colorectal lesion
JNET classification n, (%)
Histologic findings
HP/SSP LGD HGD
Carcinoma
SM-s SM-d
Type 2B-low 437 (100) 181 (41) 232 (53) 16 (4) 8 (2)
Type 2B-high 94 (100) 15 (16) 20 (21) 59 (63)
Total 531 0 181 247 36 67
JNET, Japan NBI Expert Team; HP, hyperplastic lesion; SSP, sessile serrated polyp; LGD, low-grade dysplasia; HGD, high-grade dysplasia; SM-s, superficial submucosal invasive
carcinoma (<1000 mm); SM-d, deep submucosal invasive carcinoma (1000 mm).
TABLE 6. Relationship between the JNET classification with subtyping of Type 2B and histologic findings in colorectal lesion
JNET classification n, (%)
Histologic findings
HP/SSP LGD HGD
Carcinoma
SM-s SM-d
Type 2B-low 656 (100) 297 (45) 321 (49) 30 (5) 8 (1)
Type 2B-high 143 (100) 19 (13) 37 (26) 87 (61)
Total 799 0 297 430 67 95
JNET, Japan NBI Expert Team; HP, hyperplastic lesion; SSP, sessile serrated polyp; LGD, low-grade dysplasia; HGD, high-grade dysplasia; SM-s, superficial submucosal invasive
carcinoma (<1000 mm); SM-d, deep submucosal invasive carcinoma (1000 mm).
Diagnostic performance of JNET classiﬁcation Sumimoto et alwas observed for Type 2B-low lesions (P Z .0571 for type
2B-low and P Z .589 for type 2B-high; Table 9).DISCUSSION
In general, there is a consensus in Japan that LGD,
HGD, and SM-s carcinoma are considered to be appro-
priate for endoscopic resection.32,33 Additionally, SM-
d carcinoma should be surgically resected because of
the possibility of lymph node metastasis. As a principle,
en bloc resection is essential for carcinoma to obtain a
precise histologic diagnosis.33,34 Detailed histologic in-
formation can only be acquired from a complete spec-
imen, and having this information enables us to make
decisions regarding the curability and the necessity of
additional surgical treatment in each case.35,36 Because
HGD (which is generally regarded as an intramucosal
carcinoma in Japan) can potentially invade the submuco-
sal layer, both HGD and SM-s carcinoma require an en
bloc resection technique, such as endoscopic mucosal
resection (EMR) or endoscopic submucosal dissection
(ESD).32,37,38 Unlike carcinoma, LGD can be treated
not only using en bloc EMR or ESD but instead using
piecemeal EMR to achieve a complete cure.32 For
carcinoma within an adenomatous component, the
cancerous areadif it can be detected in advanced
should be carefully resected en bloc to obtain a
precise histologic diagnosis, and fragmentation is
allowed for the noncancerous area (this is so-called
planned piecemeal EMR).39-42 Thus, the treatment706 GASTROINTESTINAL ENDOSCOPY Volume 86, No. 4 : 2017methods that are adequate for each lesion differ based
on their histologic features.33 In this way, a precise
optical diagnosis before treatment is very important for
selecting an adequate treatment procedure, such as
piecemeal EMR, en bloc endoscopic resection (en bloc
EMR/ESD), or surgery.43,44
Regarding the JNET Type 2B subtyping, about 80% of
Type 2B lesions were classiﬁed as Type 2B-low. Further,
the large majority of the Type 2B-low lesions were LGD,
HGD, or SM-s carcinoma. Because almost all Type 2B-
low lesions were LGD, HGD, or SM-s carcinoma, Type
2B-low can be regarded as a reliable indicator for endo-
scopic resection when examining the various histologic
types of Type 2B cases. On the other hand, about 60%
of Type 2B-high lesions were SM-d carcinoma, which re-
quires surgery, whereas the remaining lesions were
HGD or SM-s carcinoma. This ﬁnding suggests that
Type 2B-high is not a reliable indicator for surgery.
Thus, for Type 2B-low lesions, which comprise about
80% of Type 2B lesions, endoscopic treatment can be a
ﬁrst choice in the therapeutic strategy process. For
Type 2B-high lesions, because they alone cannot be
identiﬁed with SM-d carcinoma, further examination is
necessary to differentiate HGD and SM-s carcinoma
from SM-d carcinoma, thereby avoiding unnecessary sur-
gery. To determine the appropriate treatment method
(endoscopic resection or surgery) for Type 2B-high le-
sions, pit pattern diagnosis using chromoagents45,46 or
endoscopic ultrasonography47,48 is necessary to diag-
nose the correct invasion depth. However, no additional
examination is necessary for Type 2B-low lesionswww.giejournal.org
TABLE 8. Relationship between the JNET classification with subtyping of type 2B and histologic findings in superficial colorectal lesion
JNET classification n, (%)
Histologic findings
HP/SSP LGD HGD
Carcinoma
SM-s SM-d
Type 2B-low 219 (100) 116 (53) 89 (41) 14 (6)
Type 2B-high 49 (100) 4 (8) 17 (35) 28 (57)
Total 268 0 116 93 31 28
JNET, Japan NBI Expert Team; HP, hyperplastic lesion; SSP, sessile serrated polyp; LGD, low-grade dysplasia; HGD, high-grade dysplasia; SM-s, superficial submucosal invasive
carcinoma (<1000 mm); SM-d, deep submucosal invasive carcinoma (1000 mm).
TABLE 9. Relationship between the JNET classification with subtyping of Type 2B and histologic findings in polypoid type and superficial type
JNET classification Gross type n (100)
Histologic findings
P valueLGD SM-s (%) SM-d (%)
Type 2B-low Polypoid 437 (100) 429 (98) 8 (2) .0571
Superficial 219 (100) 219 (100) 0 (0)
Type 2B-high Polypoid 94 (100) 35 (37) 59 (63) .5890
Superficial 49 (100) 21 (43) 28 (57)
Total 799 704 95
JNET, Japan NBI Expert Team; LGD, low-grade dysplasia; SM-s, superficial submucosal invasive carcinoma (<1000 mm); SM-d, deep submucosal invasive carcinoma (1000 mm).
Sumimoto et al Diagnostic performance of JNET classiﬁcationbecause most of these are appropriate for endoscopic
resection (Fig. 3). The fact that nearly 80% of Type 2B
lesions (subtyped in Type 2B-low) can be selected for
the appropriate treatment method by NBI magnifying
endoscopy alone provides simplicity, efﬁciency, and
cost beneﬁts for the management of Type 2B lesions
in daily colonoscopic practice.
Regarding the variability of Type 2B subtyping, both
interobserver and intraobserver agreements were good.
Type 2B subtyping may be performed as easily as the
JNET classiﬁcation in clinical practice. Of course, if there
is low conﬁdence in the diagnosis for any lesion or if the
lesion is difﬁcult to subclassify into either Type 2B-low or
2B-high, then another examination should be performed
in addition to NBI magniﬁcation to arrive at a diagnosis
with high conﬁdence.
The JNET classiﬁcation is an NBI magnifying endo-
scopic classiﬁcation of colorectal tumors, the essence
of which was based on the NICE classiﬁcation. JNET
Type 1 and 3 correspond to NICE Type 1 and 3, respec-
tively. Additionally, JNET Type 2A and 2B correspond to
the NICE Type 2 subclassiﬁcation.24 The ﬁndings of
color that are used in the NICE classiﬁcation are
unnecessary for the JNET classiﬁcation because
magniﬁcation does not estimate color. Using ﬁne NBI
magniﬁcation, we have found it to be possible to
differentiate LGD (JNET Type 2A) from HGD/SM-s carci-
noma (JNET Type 2B), both of which had been classiﬁed
as NICE Type 2 lesions. As we reported previously,
JNET Type 1, 2A, and 3 are highly reliable indicators ofwww.giejournal.orgHP/SSP, LGD, and SM-d carcinoma, respectively. On
the other hand, the ability of JNET Type 2B as a means
of diagnosing HGD and SM-s carcinoma is lower than
the abilities of the other 3 types because of a variety of
histologies.25 This is the reason we believed it was
necessary to subtype Type 2B lesions, as a means of
providing a more detailed optical diagnosis for these
lesions.
In this study we also focused on the gross type of the
lesions. Generally, colorectal tumors generally exhibit
various gross types and growth patterns. The histologic
characteristics and molecular biologic features are
different for each gross type.26,27,49 Previously, we re-
ported that the NBI magnifying ﬁndings differ according
to growth pattern.50 In this study we estimated the
diagnostic performance of the JNET classiﬁcation for
polypoid lesions and superﬁcial lesions separately. As
shown in Results, there was no signiﬁcant difference in
overall diagnostic accuracy between the gross types.
The sensitivities of each type seem to be different
between polypoid lesions and superﬁcial lesions. Note
that overall diagnostic accuracy is a weighted average of
sensitivity and speciﬁcity, with weights determined by
the relative proportions of true positives and true
negatives. As shown in Table 4, the speciﬁcity is high
and there are mostly true negatives. Accordingly, the
level of sensitivity may play a small role in determining
the value of overall diagnostic accuracy. We expected
no signiﬁcant difference in the characteristics of the
Type 2B subtype between the gross types as well as theVolume 86, No. 4 : 2017 GASTROINTESTINAL ENDOSCOPY 707
NBI: narrow-band imaging, IEE: image enhanced endoscopy, SSP: sessile serrated polyp,
WLI: white-light imaging, EUS: endoscopic ultrasonography
       Indigo carmine dye
spraying is essential
for some cases.
NBI
magnification
(IEE)
SSP needs removal in some cases.
Follow-up
(does not require
chromoendoscopy)
Endoscopic treatment
(does not require
chromoendoscopy)
pit pattern diagnosis
(magnifying
chromoendoscopy)
Surgery
(does not require
chromoendoscopy)
             WLI observation and EUS are useful
for making the final diagnosis.
Detection
JNET
classification
1
2A
2B
3
2B-low
2B-high
Figure 3. Strategy for treatment of colorectal lesions using Japan NBI Expert Team (JNET) type 2B subtype. With JNET classiﬁcation, type 1 lesions, which
are suspected as hyperplastic polyp/ sessile serrated polyp (SSP), could be followed up. (Some SSPs over 10-mm diameter need to be removed.) Type 2A
lesions, which are suspected as low-grade dysplasia, should be removed by endoscopic treatment, and type 3 lesions, which are suspected as deep sub-
mucosal invasive carcinoma, need surgical treatment. For type 2B lesions, we subclassify them into 2B-low and 2B-high. Almost type 2B-low lesions are
indicative for endoscopic treatment, whereas type 2B-high lesions needs further examinations, such as magnifying chromoendoscopy or EUS, to make a
precise invasion depth diagnose for selection of appropriate treatment method.
Diagnostic performance of JNET classiﬁcation Sumimoto et alJNET classiﬁcation. As shown in Table 9, the proportions
of histologic ﬁndings for Type 2B-low lesions were almost
signiﬁcantly different between polypoid and superﬁcial
lesions, with a P Z .0571. The reason for this near-
statistically signiﬁcant difference might be that no super-
ﬁcial SM-d carcinoma appeared to be JNET Type 2B-low.
Generally, SM-d carcinomas correspond to JNET Type 3.
Some advanced lesions of the polypoid type could have
a slightly less irregular NBI appearance than Type 3
because the surface microvillous structure remains, which
seldom happens to superﬁcial advanced lesions. Thus, it
can be suggested that the JNET classiﬁcation, and also
Type 2B subtyping, can be applied to high diagnostic ac-
curacy for characterizing colorectal tumors (ie, as non-
neoplasia vs dysplasia vs SM invasive carcinoma) for
both polypoid lesion and superﬁcial lesion.
In conclusion, regardless of the gross type, the JNET
classiﬁcation provides useful criteria for optical histologic
diagnoses of colorectal lesions. Our proposal of Type 2B
subtyping may improve the diagnostic performance of
the JNET classiﬁcation and contribute to daily colono-
scopic practice.708 GASTROINTESTINAL ENDOSCOPY Volume 86, No. 4 : 2017REFERENCES
1. Wallace MB, Crook JE, Coe S, et al. Accuracy of in vivo colorectal polyp
discrimination by using dual-focus high-definition narrow-band imag-
ing colonoscopy. Gastrointest Endosc 2014;80:1072-87.
2. Kaltenbach T, Rex DK, Wilson A, et al. Implementation of optical diag-
nosis for colorectal polyps: standardization of studies is needed. Clin
Gastroenterol Hepatol 2015;13:6-10.
3. Horimatsu T, Sano Y, Tanaka S, et al. Next-generation narrow band im-
aging system for colonic polyp detection: a prospective multicenter
randomized trial. Int J Colorectal Dis 2015;30:947-54.
4. Utsumi T, Iwatate M, Sano W, et al. Polyp detection, characterization,
and management using narrow-band imaging with/without magnifi-
cation. Clin Endosc 2015;48:491-7.
5. Rex DK, Clodfelter R, Rahmani F, et al. Narrow-band imaging versus
white light for the detection of proximal colon serrated lesions: a ran-
domized, controlled trial. Gastrointest Endosc 2016;83:166-71.
6. Sakamoto T, Matsuda T, Aoki T, et al. Time saving with narrow-band
imaging for distinguishing between neoplastic and non-neoplastic
small colorectal lesions. J Gastroenterol Hepatol 2012;27:351-5.
7. Leifeld L, Rogler G, Stallmach A, et al. White-light or narrow-band im-
aging colonoscopy in surveillance of ulcerative colitis: a prospective
multicenter study. Clin Gastroenterol Hepatol 2015;13:1776-81.
8. Kobayashi Y, Hayashino Y, Jackson JL, et al. Diagnostic performance of
chromoendoscopy and narrow band imaging for colonic neoplasms: a
meta-analysis. Colorectal Dis 2012;14:18-28.www.giejournal.org
Sumimoto et al Diagnostic performance of JNET classiﬁcation9. Iwatate M, Sano Y, Hattori S, et al. The addition of high magnifying
endoscopy improves rates of high confidence optical diagnosis of
colorectal polyps. Endosc Int Open 2015;3:140-5.
10. Saligram S, Rastogi A. Methods to become a high performer in charac-
terization of colorectal polyp histology. Best Pract Res Clin Gastroenter-
ol 2015;29:651-62.
11. Tanaka S, Sano Y. Aim to unify the narrow band imaging (NBI)magnifying
classification for colorectal tumors: current status in Japan from a sum-
mary of the consensus symposium in the 79th annual meeting of the
Japan Gastroenterological Endoscopy Society. Dig Endosc 2011;23:131-9.
12. Hewett DG, Kaltenbach TR, Sano Y, et al. Validation of a simple classi-
fication system for endoscopic diagnosis of small colorectal polyps us-
ing narrow-band imaging. Gastroenterology 2012;143:599-607.
13. Hayashi N, Tanaka S, Hewett DG, et al. Endoscopic prediction of deep
submucosal invasive carcinoma: validation of the narrow-band imag-
ing international colorectal endoscopic (NICE) classification. Gastroint-
est Endosc 2013;78:625-32.
14. Wani S, Rastogi A. Narrow-band imaging in the prediction of submu-
cosal invasive colon cancer: how “NICE” is it? Gastrointest Endosc
2013;78:633-6.
15. Wallace MB. Not so NICE to be serrated. Gastrointest Endosc 2013;78:910-1.
16. Hirata M, Tanaka S, Oka S, et al. Evaluation of microvessels in colorectal
tumors by narrow band imaging magnification. Gastrointest Endosc
2007;66:945-52.
17. Kanao H, Tanaka S, Oka S, et al. Narrow band imaging magnification
predicts the histology and invasion depth of colorectal tumors. Gastro-
intest Endosc 2009;69:631-6.
18. Oba S, Tanaka S, Oka S, et al. Characterization of colorectal tumors us-
ing narrow-band imaging magnification: combined diagnosis with
both pit pattern and microvessel features. Scand J Gastroenterol
2010;45:1084-92.
19. Oka S, TanakaS, Takata S, KanaoH, et al. Clinical usefulness of narrowband
imaging magnifying classification for colorectal tumors based on both
surface pattern and microvessel features. Dig Endosc 2011;23:101-5.
20. Sano Y, Ikematsu H, Fu KI, et al. Meshed capillary vessels by use of
narrow-band imaging for differential diagnosis of small colorectal
polyps. Gastrointest Endosc 2009;69:278-83.
21. Ikematsu H, Matsuda T, Emura F, et al. Efficacy of capillary pattern type
IIIA/IIIB by magnifying narrow band imaging for estimating depth of
invasion of early colorectal neoplasms. BMC Gastroenterol 2010;10:33.
22. Wada Y, Kudo S, Kashida H, et al. Diagnosis of colorectal lesions with
the magnifying narrow-band imaging system. Gastrointest Endosc
2009;70:522-31.
23. Nikami T, Saito S, Tajiri H, et al. The evaluation of histological atypia
and depth of invasion of colorectal lesions using magnified endoscopy
with narrow-band imaging. Gastroenterol Endosc 2009;51:10-9.
24. Sano Y, Tanaka S, Kudo SE, et al. NBI magnifying endoscopic classifica-
tion of colorectal tumors proposed by the Japan NBI Expert Team
(JNET). Dig Endosc 2016;28:526-33.
25. Sumimoto K, Tanaka S, Shigita K, et al. Clinical impact and characteris-
tics of the NBI magnifying endoscopic classification of colorectal tu-
mors proposed by the Japan NBI Expert Team (JNET). Gastrointest
Endosc 2016;85:816-21.
26. Kaneko K, Fujii T, Kato S, et al. Growth patterns and genetic changes of
colorectal carcinoma. Jpn J Clin Oncol 1998;28:196-201.
27. George SM, Makinen MJ, Jernvall P, et al. Classification of advanced
colorectal carcinomas by tumor edge morphology: evidence for
different pathogenesis and significance of polypoid and nonpolypoid
tumors. Cancer 2000;89:1901-9.
28. The Paris endoscopic classification of superficial neoplastic lesions:
esophagus, stomach, and colon: November 30 to December 1, 2002.
Gastrointest Endosc 2003;58:S3-43.
29. Boman FT, Carneiro F, Hruban RH, et al. WHO classification of tumours
of the digestive system, 4th ed. Lyon, France: IARC; 2010.www.giejournal.org30. Watanabe T, Itabashi M, Shimada Y, et al. Japanese Society for Cancer
of the Colon and Rectum (JSCCR) guidelines 2014 for treatment of
colorectal cancer. Int J Clin Oncol 2015;20:207-39.
31. Landis JR, Koch GG. The measurement of observer agreement for cat-
egorical data. Biometrics 1977;33:159-74.
32. Tanaka S, Kashida H, Saito Y, et al. JGES guidelines for colorectal endo-
scopic submucosal dissection/endoscopic mucosal resection. Dig En-
dosc 2015;27:417-34.
33. Tanaka S, Tesasaki M, Hayashi N, et al. Warning for unprincipled colo-
rectal endoscopic submucosal dissection: accurate diagnosis and
reasonable treatment strategy. Dig Endosc 2013;25:107-16.
34. Tanaka S, Tamegai Y, Tsuda S, et al. Multicenter questionnaire survey
on the current situation of colorectal endoscopic submucosal dissec-
tion in Japan. Dig Endosc 2010;22:S2-8.
35. Takeuchi Y, Ohta T, Matsui F, et al. Indication, strategy and outcomes of
endoscopic submucosal dissection for colorectal neoplasm. Dig En-
dosc 2012;241:100-4.
36. Tanaka S, Terasaki M, Kanao H, et al. Current status and future perspec-
tives of endoscopic submucosal dissection for colorectal tumors. Dig
Endosc 2012;24:73-9.
37. Toll AD, Fabius D, Hyslop T, et al. Prognostic significance of high-grade
dysplasia in colorectal adenomas. Colorectal Dis 2011;13:370-3.
38. Cha JM, Lee JI, Joo KR, et al. Clinicopathological risk factors of early car-
cinoma in colorectal neoplasias according to Japanese and Western
criteria. Hepatogastroenterology 2015;62:25-9.
39. Kume K, Murata I, Yoshikawa I, et al. Endoscopic piecemeal mucosal
resection of large colorectal tumors. Hepatogastroenterology
2005;52:429-32.
40. Uraoka T, Saito Y, Matsuda T, et al. Endoscopic indications for endo-
scopic mucosal resection of laterally spreading tumours in the colorec-
tum. Gut 2006;55:1592-7.
41. Oka S, Tanaka S, Kanao H, et al. Therapeutic strategy for colorectal
laterally spreading tumor. Dig Endosc 2009;21:S43-6.
42. Terasaki M, Tanaka S, Oka S, et al. Clinical outcomes of endoscopic sub-
mucosal dissection and endoscopic mucosal resection for laterally
spreading tumors larger than 20 mm. J Gastroenterol Hepatol
2012;27:734-40.
43. Tanaka S, Oka S, Chayama K, et al. Colorectal endoscopic submucosal
dissection: present status and future perspective, including its differen-
tiation from endoscopic mucosal resection. J Gastroenterol 2008;43:
641-51.
44. Saito Y, Sakamoto T, Nakajima T, et al. Colorectal ESD: current indica-
tions and latest technical advances. Gastrointest Endosc Clin North
Am 2014;24:245-55.
45. Sakamoto T, Saito Y, Nakajima T, et al. Comparison of magnifying
chromoendoscopy and narrow-band imaging in estimation of early
colorectal cancer invasion depth: a pilot study. Dig Endosc 2011;23:
118-23.
46. Hayashi N, Tanaka S, Kanao H, et al. Relationship between narrow-
band imaging magnifying observation and pit pattern diagnosis in
colorectal tumors. Digestion 2013;87:53-8.
47. Ozawa S, Tanaka S, Hayashi N, et al. Risk factors for vertical incomplete
resection in endoscopic submucosal dissection as total excisional bi-
opsy for submucosal invasive colorectal carcinoma. Int J Colorectal
Dis 2013;28:1247-56.
48. Mukae M, Kobayashi K, Sada M, et al. Diagnostic performance of EUS
for evaluating the invasion depth of early colorectal cancers. Gastroint-
est Endosc 2015;81:682-90.
49. Sakashita M, Aoyama N, Maekawa S, et al. Flat-elevated and depressed,
subtypes of flat early colorectal cancers, should be distinguished by
their pathological features. Int J Colorectal Dis 2000;15:275-81.
50. Takata S, Tanaka S, Hayashi N, et al. Characteristic magnifying narrow-
band imaging features of colorectal tumors in each growth type. Int J
Colorectal Dis 2013;28:459-68.Volume 86, No. 4 : 2017 GASTROINTESTINAL ENDOSCOPY 709
